EGFR signaling promotes resistance to CHK1 inhibitor prexasertib in triple negative breast cancerKevin J. Lee, Natalie R. Gassman, Leigh Ann Wiggins et al.|Cancer Drug Resistance|2021Cited by 11
Abstract 1140: Characterization of a novel PDE10 inhibitor in lung tumor cells and an orthotopic mouse model of lung cancerVerónica Ramírez‐Alcántara, Gary A. Piazza, Bing Zhu et al.|Cancer Research|2017Cited by 1
Abstract 3464: Vitamin D supplementation to improve doxorubicin-induced cardiotoxicity in triple negative breast cancersKevin J. Lee, Natalie R. Gassman, Griffin Wright et al.|Cancer Research|2020Cited by 0